Cost of managing chronic hepatitis B in the UK

被引：0
|
作者：
Brown, R
De Cock, E
Iloeje, U
机构：
[1] MEDTAP Int, London, England
[2] Bristol Myers Squibb Co, Wallingford, CT 06492 USA
来源：
VALUE IN HEALTH | 2003年 / 6卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)61923-7
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：755 / 755
页数：1
相关论文
共 50 条
  • [31] Challenges in managing patients in Australia with chronic hepatitis B: the General Practitioners' perspective
    Wallace, Jack
    Hajarizadeh, Behzad
    Richmond, Jacqui
    McNally, Stephen
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH, 2013, 37 (05) : 405 - 410
  • [32] Managing resistance to analogue antiviral drugs in a chronic compensated hepatitis B patient
    Bronowicki, Jean-Pierre
    Barraud, Helene
    Couzigou, Patrice
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2006, 30 (10): : S17 - S19
  • [33] Understanding and managing polypharmacy in patients with chronic hepatitis B (CHB) or C (CHC)
    Nascimento, Yone A.
    Cruz, Leticia G.
    dos Santos, Tayane O.
    Silva, Luciana D.
    Velanes Neto, Elson C.
    Teixeira, Rosangela
    de Oliveira, Djenane Ramalho
    HEPATOLOGY, 2012, 56 : 1094A - 1095A
  • [34] Cost-effectiveness of sofosbuvir for the treatment of chronic hepatitis C infected patients in the UK
    Cure, Sandrine
    Guerra, Ines
    Dusheiko, Geoffrey M.
    HEPATOLOGY, 2014, 60 : 660A - 660A
  • [35] Cost-effectiveness of telbivudine versus lamivudine for chronic hepatitis B
    Wong, J. B.
    Pauker, S. G.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S199 - S199
  • [36] Cost-effectiveness analysis of lamivudine for the treatment of chronic hepatitis B
    Crowley, SJ
    Tognarini, D
    Desmond, PV
    Lees, M
    PHARMACOECONOMICS, 2000, 17 (05) : 409 - 427
  • [37] Cost-effectiveness of lamivudine for the treatment of chronic hepatitis B in Canada
    Haiderali, AM
    Villa, K
    Schrammel, P
    HEPATOLOGY, 1999, 30 (04) : 347A - 347A
  • [38] Cost-effectiveness of nucleoside/nucleotide analogues in chronic hepatitis B
    Almeida, Alessandra Maciel
    da Silva, Anderson Lourenco
    Ruas Brandao, Cristina Mariano
    Cherchiglia, Mariangela Leal
    Gurgel Andrade, Eli Iola
    Araujo de Oliveira, Gustavo Laine
    Carmo, Ricardo Andrade
    Acurcio, Francisco de Assis
    REVISTA DE SAUDE PUBLICA, 2012, 46 (06): : 942 - 949
  • [39] Cost-effectiveness of telbivudine versus lamivudine for chronic hepatitis B
    Wiens, Astrid
    Venson, Rafael
    Correr, Cassyano Januario
    Pontarolo, Roberto
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2011, 15 (03): : 225 - 230
  • [40] Cost-Effectiveness Analysis of Lamivudine for the Treatment of Chronic Hepatitis B
    Steven J. Crowley
    David Tognarini
    Paul V. Desmond
    Michael Lees
    PharmacoEconomics, 2000, 17 : 409 - 427
12345